Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06911021
What this trial is testing

68Ga-FAPI-46 in Staging of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaPET / CTFAPI+2 more
Centre Hospitalier Universitaire Vaudois 20
Early research (Phase 1)Active Not RecruitingNCT04616534
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+19 more
National Cancer Institute (NCI) 14
Early research (Phase 1)Ended earlyNCT03948763
What this trial is testing

MRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)

Who this might be right for
NeoplasmsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms+1 more
Merck Sharp & Dohme LLC 70
Testing effectiveness (Phase 2)WithdrawnNCT04481204
What this trial is testing

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT02960594
What this trial is testing

HTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

Who this might be right for
Breast CancerLung CancerPancreatic Cancer+6 more
Inovio Pharmaceuticals 93
Large-scale testing (Phase 3)Looking for participantsNCT07165951
What this trial is testing

Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 566
Not applicableUnknownNCT03033186
What this trial is testing

Everolimus TDM to Predict Long Term Toxicity

Who this might be right for
Breast CancerRenal Cell CarcinomaPancreatic Neuroendocrine Tumour+2 more
Maastricht University Medical Center 40
Early research (Phase 1)Active Not RecruitingNCT05277766
What this trial is testing

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+5 more
University Hospital, Ghent 45
Not applicableStudy completedNCT04920019
What this trial is testing

Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery

Who this might be right for
HepatomaPancreas Cancer
Mahidol University 140
Large-scale testing (Phase 3)UnknownNCT04167007
What this trial is testing

FOLFOX vs Gemcitabine in Patients With Metastatic Pancreatic Cancer Non-fit to FOLFIRINOX

Who this might be right for
Pancreatic Adenocarcinoma
Assistance Publique - Hôpitaux de Paris 400
Not applicableStudy completedNCT05483257
What this trial is testing

Molecular Subtyping for Prognosis Evaluation in Resected Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer Resectable
BAIYONG SHEN 226
Testing effectiveness (Phase 2)Study completedNCT00075439
What this trial is testing

Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+6 more
National Cancer Institute (NCI) 90
Not applicableLooking for participantsNCT07760012
What this trial is testing

68Ga-SorB PET/CT Imaging in Patients With Solid Tumors

Who this might be right for
Melanoma (Skin Cancer)Hepatocellular CarcinomaLung Cancer+3 more
Peking University Third Hospital 50
Not applicableLooking for participantsNCT05356039
What this trial is testing

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreas CancerPancreas NeoplasmPancreas Disease+6 more
Umeå University 300
Not applicableStudy completedNCT03982446
What this trial is testing

Germline Mutations in Pancreatic Adenocarcinoma

Who this might be right for
Germline Mutation AbnormalityPancreatic CancerPredisposition, Genetic+1 more
Hellenic Cooperative Oncology Group 549
Early research (Phase 1)Study completedNCT01674556
What this trial is testing

Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Haukeland University Hospital 25
Testing effectiveness (Phase 2)Study completedNCT02611024
What this trial is testing

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

Who this might be right for
Advanced Solid TumorsGlioblastomaSoft Tissue Sarcoma (Excluding GIST)+9 more
PharmaMar 316
Testing effectiveness (Phase 2)Study completedNCT04493060
What this trial is testing

Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
Mayo Clinic 22
Not applicableActive Not RecruitingNCT05038254
What this trial is testing

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

Who this might be right for
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+42 more
M.D. Anderson Cancer Center 750
Testing effectiveness (Phase 2)Study completedNCT01053013
What this trial is testing

Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal Cancer

Who this might be right for
Pancreatic Adenocarcinoma Non-resectablePancreatic Adenocarcinoma MetastaticColorectal Cancer Metastatic
The Rogosin Institute 58
Next Page